Sperm Banking - U.S. Regulation
"Marketed Sperm: Use and Regulation in the United States."
Published in Blood Weekly, June 12th, 1995
According to the authors' abstract of an article published in Fertility and Sterility, "Objective: To collate information relating to the current use of marketed semen for therapeutic donor insemination (DI) in the United States. Data Identification: Literature was identified by Medline search and government document review. Literature Selection: Materials selected for review included empirical studies, policy reviews, legal documents, and government surveys relating to use of donor sperm. Results: Use of marketed (donor) sperm is associated with significant medical, genetic, and psychological risk. These risks directly affect the individuals...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1995-06-12)
More Articles from Blood Weekly
- Transplantation
Earlier BMT from Unrelated Donors Should Be Encouraged - Atherosclerosis
Vein Grafts Genetically Engineered To Resist Failure - Biomedical Research
FDA Contemplates Transplant Regulations - Chagas Disease
FDA Clearance Received To Market Test - Chronic Liver Disease
Autoantibodies to Non-Muscle Myosin Found in Three Patients - DNA Immunization
Particle-Mediated DNA Delivery to Skin Has Many Advantages - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
